<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230202057309N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-03-16</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Evaluation of post-op complications of envelope flap and comma flap for impacted third molar</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of post-op complications of two different flap designs for impacted third mandibular molar surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>25</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68415</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Crossover, Purpose: Supportive, Randomization description: The impacted tooth will assigned into two lingually based comma flap(group A) and envelope flap(group B), by flipping a coin. For choosing which quadrant to start with, also there will be a coin flipping, Blinding description: It will be explained to the patients that one distinct flap design will be used for every impacted mandibular third molar on each quadrant. But they will be not informed, which one of those two flap designs will be used on which quadrant.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Post-op complications comparison of two comma and envelope flap design in impacted third mandibualr surgery.</hc_freetext>
      <i_freetext>Intervention 1: Control group:The impacted tooth will assigned into two lingually based comma flap(group A) and envelope flap(group B), by flipping a coin. For choosing which quadrant to start with, also there will be a coin flipping. Intervention 2: Intervention group: The impacted tooth will assigned into two lingually based comma flap(group A) and envelope flap(group B), by flipping a coin. For choosing which quadrant to start with, also there will be a coin flipping.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
all of the patients' data except their name and contact information, will be shared.

When:
6 months after publishing of the results.

To whom:
People who practice in medical field, like medical doctors and dentists.

Conditions:
Access permit to data will only be allowed in case of evaluating the exactitude of the study and using its benefits for treating patients.

Where to obtain:
1) Farid Ghasemi
f.gh1372@gmail.com
(+98)9134728100
Skype: f.gh1372
2) Yousef Kananizadeh
dr.kananizadehy@gmail.com

How to obtain:
Please contact with one of the two person mentioned, by e-mail or phone. after evaluating the request, in 2 weeks the data will be sent.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Farid Ghasemi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 76, Ladan alley, Farabi 6 street, Tohid Sharghi street, Sepahan Shahr, Esfahan</address>
        <city>Esfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8179993583</zip>
        <telephone>+98 31 3651 6267</telephone>
        <email>f.gh1372@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Farid Ghasemi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 76, Ladan alley, Farabi 6 street, Tohid Sharghi street, Sepahan Shahr, Esfahan</address>
        <city>Esfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8179993583</zip>
        <telephone>+98 31 3651 6267</telephone>
        <email>f.gh1372@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients who have bilateral and symmetrical impacted mandibular third molar
Patients who have class 1,2,A,B impacted mandibular third molar, based on Pell and Gregory classification
Patients who have not any systemic or underlying disease
Patients whom impacted mandibular third molar has no symptom such as pain, edema and trismus
Patients whom root of impacted mandibular third molar has developed more than one-third
Patients who have no acute periodontal disease</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K01.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Impacted teeth</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group:The impacted tooth will assigned into two lingually based comma flap(group A) and envelope flap(group B), by flipping a coin. For choosing which quadrant to start with, also there will be a coin flipping.</i_keyword>
      <i_keyword>Intervention group: The impacted tooth will assigned into two lingually based comma flap(group A) and envelope flap(group B), by flipping a coin. For choosing which quadrant to start with, also there will be a coin flipping.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain: post-operative pain will be measured by Visual Analog Scale. In this scale, the patients will be asked to show the intensity of the pain which is experienced by choosing a number(between 0-10) on a horizontal line. Pain in this descriptive scale is categorized to 6 levels: 0= no pain, 1-3= mild pain, 4-5= moderate pain, 6-7= painful, 7-8= sever pain and 10= unbearable pain. The paitients will be asked to report the pain score on its worst severity time on a day. Timepoint: Will be measured on the first, third and seventh post-operative day. Method of measurement: Visual Analog Scale.</prim_outcome>
      <prim_outcome>Edema: the severity of post-operative edema will be measured by the pre-operative difference between the two fixed mandibular angle and lip commissure points on the patients' face and the post-operative one. Timepoint: Will be measured on the first, third and seventh post-operative day. Method of measurement: The pre-operative difference between the two fixed mandibular angle and lip commissure points on the patients' face and the post-operative one (in milimeter).</prim_outcome>
      <prim_outcome>Trismus: will be measured post-operatively. for this purpose the inter-incisal distance will be measured. if the distance is less than 25 milimiter, the presence of trismus will be considered. Timepoint: Will be measured on the first, third and seventh post-operative day. Method of measurement: the maximum inter-incisal distance (in milimeter).</prim_outcome>
      <prim_outcome>Wound dehiscence: to a dehiscence more than 1.5 centimeter square, number 3, less than 1 centimeter square, number 2 and less than 0.5 centimeter square, number 1 will be assigned. in case of no dehiscence number 0 will be considered. Timepoint: Will be measured on the first, third and seventh post-operative day. Method of measurement: the amount of post-operative wound dehiscence (in centimeter square).</prim_outcome>
      <prim_outcome>Alveolar osteitis: will be considered post-operative pain in or around the socket of the extracted impacted tooth or partial/total loss of the blood clot in the socket (yes or no). Timepoint: Will be measured on the first, third and seventh post-operative day. Method of measurement: post-operative pain in or around the socket of the extracted impacted tooth or partial/total loss of the blood clot in the socket (yes or no).</prim_outcome>
      <prim_outcome>Lingual nerve paraesthesia: in order to evaluate any post-operative injury or paraesthesia to lingual nerve, changes on the lateral surface of tounge will be investigated. Timepoint: Will be measured on the first, third and seventh post-operative day. Method of measurement: any post-operative injury,paraesthesia or aneasthesia on the lateral surface of tounge (any changes in sensation , yes and no changes in sensation, no).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-03-07</approval_date>
        <contact_name>Ethics committee of Islamic Azad University Tabriz branch</contact_name>
        <contact_address>Tabriz Islamic Azad Medical University, Jadde Basmanj, East Azerbaijan Province, Iran Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
